Table 1 Molecular profiles of patients with perfusion-diffusion mismatch (PDM) and clinical-diffusion mismatch (CDM) who received or did not receive thrombolytic treatment
From: Interleukin-10 facilitates the selection of patients for systemic thrombolysis
PDM (n = 100) | CDM (n = 184) | |||||
|---|---|---|---|---|---|---|
NO (n = 21) | YES (n = 79) | p | NO (n = 92) | YES (n = 92) | p | |
NSE (ng/mL) | 22.4 ± 9.0 | 20.7 ± 6.1 | 0.449 | 24.6 ± 8.3 | 21.4 ± 5.8 | 0.002 |
IL-10 (pg/mL) | 8.8 ± 7.0 | 22.5 ± 14.9 | <0.0001 | 8.6 ± 8.0 | 30.9 ± 14.7 | <0.0001 |
Glutamate (μM) | 150.9 ± 102.2 | 207.7 ± 177.9 | 0.290 | 152.5 ± 91.5 | 226.6 ± 186.9 | 0.031 |
IL-6 (pg/mL) | 9.9 ± 8.9 | 11.9 ± 8.6 | 0.250 | 20.9 ± 17.7 | 14.2 ± 7.6 | 0.109 |
TNF-α (pg/mL) | 10.3 ± 6.3 | 11.5 ± 8.2 | 0.774 | 12.4 ± 6.6 | 18.4 ± 12.6 | 0.003 |
MMP-9 (ng/mL) | 24.0 ± 16.6 | 21.0 ± 11.9 | 0.745 | 29.6 ± 18.4 | 20.2 ± 8.4 | <0.0001 |